Combined morphologic and karyotypic study of 59 atypical lipomatous tumors. Evaluation of their relationship and differential diagnosis with other adipose tissue tumors (a report of the CHAMP Study Group).

PubWeight™: 1.48‹?› | Rank: Top 4%

🔗 View Article (PMID 8827023)

Published in Am J Surg Pathol on October 01, 1996

Authors

J Rosai1, M Akerman, P Dal Cin, I DeWever, C D Fletcher, N Mandahl, F Mertens, F Mitelman, A Rydholm, R Sciot, G Tallini, H Van den Berghe, W Van de Ven, R Vanni, H Willen

Author Affiliations

1: Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

Articles citing this

Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Ann Surg (2003) 4.25

Clinical and molecular approaches to well differentiated and dedifferentiated liposarcoma. Curr Opin Oncol (2011) 2.39

Advances in sarcoma genomics and new therapeutic targets. Nat Rev Cancer (2011) 2.34

Neocentromeres: role in human disease, evolution, and centromere study. Am J Hum Genet (2002) 2.30

Liposarcoma: molecular genetics and therapeutics. Sarcoma (2010) 1.55

Clinicopathological analysis of metaplastic meningioma: report of 15 cases in Huashan Hospital. Chin J Cancer Res (2013) 1.21

Specificity of TLS-CHOP rearrangement for classic myxoid/round cell liposarcoma: absence in predominantly myxoid well-differentiated liposarcomas. J Mol Diagn (2000) 1.21

Genomic landscape of liposarcoma. Oncotarget (2015) 1.04

The expression of MDM2/CDK4 gene product in the differential diagnosis of well differentiated liposarcoma and large deep-seated lipoma. Br J Cancer (2000) 1.03

Expression of HMGI-C and HMGI(Y) in ordinary lipoma and atypical lipomatous tumors: immunohistochemical reactivity correlates with karyotypic alterations. Am J Pathol (1997) 0.99

Advances in the targeted therapy of liposarcoma. Onco Targets Ther (2015) 0.99

Preclinical activity of selinexor, an inhibitor of XPO1, in sarcoma. Oncotarget (2016) 0.98

Osteolipoma: radiological, pathological, and cytogenetic analysis of three cases. Skeletal Radiol (2011) 0.96

Retroperitoneal liposarcoma: current insights in diagnosis and treatment. Front Surg (2015) 0.95

Dedifferentiated liposarcoma with rhabdomyoblastic differentiation. Virchows Arch (2005) 0.92

Characterization of liposarcoma cell lines for preclinical and biological studies. Sarcoma (2012) 0.90

Atypical lipomatous tumors of the tongue: report of six cases. Virchows Arch (2009) 0.88

Liposarcoma subtypes: identification with computed tomography and ultrasound-guided percutaneous needle biopsy. Eur Radiol (2004) 0.86

Fluorescence In Situ Hybridization for MDM2 Amplification as a Routine Ancillary Diagnostic Tool for Suspected Well-Differentiated and Dedifferentiated Liposarcomas: Experience at a Tertiary Center. Sarcoma (2015) 0.85

Large retroperitoneal liposarcoma - a series of five cases. Indian J Surg (2011) 0.82

Dynamic MRI and fine needle aspiration cytology in the evaluation of soft tissue lesions. Skeletal Radiol (2003) 0.81

Well-differentiated liposarcoma/atypical lipomatous tumor of the oral cavity: report of three cases and review of the literature. Head Neck Pathol (2012) 0.80

Clinicopathological features of atypical lipomatous tumors of the laryngopharynx. J Zhejiang Univ Sci B (2010) 0.80

An unusual case of primary colonic dedifferentiated liposarcoma. Int J Surg Case Rep (2013) 0.80

Palmar atypical lipomatous tumour with spindle cell features (well-differentiated spindle cell liposarcoma): a rare neoplasm arising in an unusual anatomical location. Virchows Arch (2005) 0.79

Combining targeted agents with modern radiotherapy in soft tissue sarcomas. J Natl Cancer Inst (2014) 0.76

Predicting dedifferentiation in liposarcoma: a proteomic approach. Virchows Arch (2013) 0.76

c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas. J Pathol (2014) 0.75

G protein pathway suppressor 2 (GPS2) acts as a tumor suppressor in liposarcoma. Tumour Biol (2016) 0.75

Atypical lipomatous tumors of the face: a controversial issue. Eur Arch Otorhinolaryngol (2006) 0.75

Articles by these authors

A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat Genet (1997) 12.94

Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study. Lancet (2001) 6.11

Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature (1993) 5.69

KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Cancer Res (2001) 5.40

Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO. Ann Oncol (2005) 5.27

Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet (2001) 4.66

Atypical and malignant solitary fibrous tumors in extrathoracic locations: evidence of their comparability to intra-thoracic tumors. Am J Surg Pathol (1998) 4.61

The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. Nat Genet (1996) 4.59

The posthumous analysis (PHA). An alternative to the conventional autopsy. Am J Clin Pathol (1996) 4.28

The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood (1999) 4.10

TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors. Am J Pathol (2000) 3.92

Spindle cell liposarcoma, a hitherto unrecognized variant of liposarcoma. Analysis of six cases. Am J Surg Pathol (1994) 3.70

Dedifferentiated liposarcoma. Clinicopathologic analysis of 32 cases suggesting a better prognostic subgroup among pleomorphic sarcomas. Am J Surg Pathol (1994) 3.47

STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications. Oncogene (2001) 3.36

Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene (2007) 3.29

Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours. Nat Genet (1995) 3.27

Malignant angiomyolipoma of the liver: a hitherto unreported variant. Histopathology (2000) 3.24

Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor. Proc Natl Acad Sci U S A (1997) 3.22

Low-grade myofibroblastic sarcoma: analysis of 18 cases in the spectrum of myofibroblastic tumors. Am J Surg Pathol (1998) 3.16

Mixed tumors and myoepitheliomas of soft tissue: a clinicopathologic study of 19 cases with a unifying concept. Am J Surg Pathol (1997) 3.15

BRD4 bromodomain gene rearrangement in aggressive carcinoma with translocation t(15;19). Am J Pathol (2001) 3.12

Solitary fibrous tumour arising at unusual sites: analysis of a series. Histopathology (1991) 3.06

Cytogenetic evidence of clonality in cutaneous benign fibrous histiocytomas: a report of the CHAMP study group. Histopathology (2000) 3.05

KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors. Am J Pathol (2000) 2.99

Follicular dendritic cell sarcoma. Clinicopathologic analysis of 17 cases suggesting a malignant potential higher than currently recognized. Cancer (1997) 2.98

The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene (2001) 2.97

18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec). Eur J Cancer (2003) 2.97

Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer (2004) 2.94

Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice. Proc Natl Acad Sci U S A (2000) 2.91

Telomere dysfunction triggers extensive DNA fragmentation and evolution of complex chromosome abnormalities in human malignant tumors. Proc Natl Acad Sci U S A (2001) 2.91

Myofibromatosis in adults, glomangiopericytoma, and myopericytoma: a spectrum of tumors showing perivascular myoid differentiation. Am J Surg Pathol (1998) 2.78

Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia. Blood (1997) 2.75

GATA3 haplo-insufficiency causes human HDR syndrome. Nature (2000) 2.73

Recurrent t(16;17)(q22;p13) in aneurysmal bone cysts. Genes Chromosomes Cancer (1999) 2.72

Primary giant cell tumor of soft tissues: a study of 22 cases. Am J Surg Pathol (2000) 2.67

Developmental changes in heparan sulfate expression: in situ detection with mAbs. J Cell Biol (1992) 2.61

Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneity. Proc Natl Acad Sci U S A (2000) 2.61

Cytogenetic profile of minimally differentiated (FAB M0) acute myeloid leukemia: correlation with clinicobiologic findings. Blood (1995) 2.59

Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours. J Pathol (2000) 2.56

Distinct haematological disorder with deletion of long arm of no. 5 chromosome. Nature (1974) 2.56

Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors. Proc Natl Acad Sci U S A (2001) 2.54

Myxoid tumours of soft tissue. Histopathology (1999) 2.53

Size, site and clinical incidence of lipoma. Factors in the differential diagnosis of lipoma and sarcoma. Acta Orthop Scand (1983) 2.51

The Greig polysyndactyly craniofacial dysmorphism syndrome: variable expression in a family. Eur J Pediatr (1981) 2.50

Nerve sheath tumours with hybrid features of neurofibroma and schwannoma: a conceptual challenge. Histopathology (1998) 2.50

Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma. Proc Natl Acad Sci U S A (1999) 2.45

Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol (1996) 2.44

Correlation between clinicopathological features and karyotype in lipomatous tumors. A report of 178 cases from the Chromosomes and Morphology (CHAMP) Collaborative Study Group. Am J Pathol (1996) 2.42

Spindle cell lipoma: a clinicopathological study with some original observations. Histopathology (1987) 2.41

A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer. Br J Cancer (2012) 2.41

Fibrosarcomatous ("high-grade") dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance. Am J Surg Pathol (1998) 2.40

Low grade fibromyxoid sarcoma: clinicopathological analysis of eleven new cases in support of a distinct entity. Histopathology (1995) 2.39

Myxofibrosarcoma. Clinicopathologic analysis of 75 cases with emphasis on the low-grade variant. Am J Surg Pathol (1996) 2.36

Epithelioid hemangioendothelioma of skin and soft tissues: clinicopathologic and immunohistochemical study of 30 cases. Am J Surg Pathol (1997) 2.31

A child, homozygous for a stop codon in exon 11, shows milder cystic fibrosis symptoms than her heterozygous nephew. J Med Genet (1990) 2.30

"Proximal-type" epithelioid sarcoma, a distinctive aggressive neoplasm showing rhabdoid features. Clinicopathologic, immunohistochemical, and ultrastructural study of a series. Am J Surg Pathol (1997) 2.25

Molecular characterization of nocardioform actinomycetes in activated sludge by 16S rRNA analysis. Microbiology (1995) 2.15

Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms. Cancer Res (1997) 2.14

Increased monozygotic twinning rate after ovulation induction. Lancet (1987) 2.12

Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein. Am J Pathol (1999) 2.12

MRI findings in acute cerebellitis. Eur Radiol (2004) 2.12

Primary vascular tumors of lymph nodes other than Kaposi's sarcoma. Analysis of 39 cases and delineation of two new entities. Am J Surg Pathol (1992) 2.07

Cellular angiofibroma: a benign neoplasm distinct from angiomyofibroblastoma and spindle cell lipoma. Am J Surg Pathol (1997) 2.04

Ancient hematoma: a unifying concept for a post-traumatic lesion mimicking an aggressive soft tissue neoplasm. Mod Pathol (1997) 2.04

Diffuse-type giant cell tumor: clinicopathologic and immunohistochemical analysis of 50 cases with extraarticular disease. Am J Surg Pathol (2000) 2.02

Marginal zone B-cell lymphomas of different sites share similar cytogenetic and morphologic features. Blood (1996) 2.02

Rearrangement of the transcription factor gene CHOP in myxoid liposarcomas with t(12;16)(q13;p11). Genes Chromosomes Cancer (1992) 1.99

Cellular benign fibrous histiocytoma. Clinicopathologic analysis of 74 cases of a distinctive variant of cutaneous fibrous histiocytoma with frequent recurrence. Am J Surg Pathol (1994) 1.96